SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ferenc Fekete, Balázs Fadgyas, Éva Papp, Ágnes Szilágyi, Zoltán Prohászka, Brigitta Müller, Gábor Kovács, The role of mannose binding lectin on fever episodes in pediatric oncology patients, Pathology & Oncology Research, 2016, 22, 1, 139

    CrossRef

  2. 2
    Clémence Merlen, Arnaud Bonnefoy, Eric Wagner, Laurence Dedeken, Jean-Marie Leclerc, Caroline Laverdière, Georges-Etienne Rivard, L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia, Pediatric Blood & Cancer, 2015, 62, 8
  3. 3
    Bernadette Prentice, Karen McKay, Hiran Selvadurai, Paul D. Robinson, Francois Abel, Dominic A. Fitzgerald, Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?, Paediatric Respiratory Reviews, 2015,

    CrossRef

  4. 4
    Bendik Lund, Agata Wesolowska-Andersen, Birgitte Lausen, Louise Borst, Kirsten Kørup Rasmussen, Klaus Müller, Helge Klungland, Ramneek Gupta, Kjeld Schmiegelow, Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia, European Journal of Haematology, 2014, 92, 4
  5. 5
    Zoe Dorothea Pana, Fekri Samarah, Rigini Papi, Charalampos Antachopoulos, Theodotis Papageorgiou, Evangelia Farmaki, Emmanuel Hatzipantelis, Athanassios Tragiannidis, Norma Vavatsi-Christaki, Dimitrios Kyriakidis, Fani Athanassiadou-Piperopoulou, Emmanuel Roilides, Mannose binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia, Pediatric Blood & Cancer, 2014, 61, 6
  6. 6
    L. F. Lundbo, Z. B. Harboe, L. N. Clausen, M. V. Hollegaard, H. T. Sorensen, D. M. Hougaard, H. B. Konradsen, M. Norgaard, T. Benfield, Mannose-Binding Lectin Gene, MBL2, Polymorphisms Are Not Associated With Susceptibility to Invasive Pneumococcal Disease in Children, Clinical Infectious Diseases, 2014, 59, 4, e66

    CrossRef

  7. 7
    Anna S. Swierzko, David C. Kilpatrick, Maciej Cedzynski, Mannan-binding lectin in malignancy, Molecular Immunology, 2013, 55, 1, 16

    CrossRef

  8. 8
    Rachel Dommett, Julia Chisholm, Malcolm Turner, Mona Bajaj-Elliott, Nigel J. Klein, Mannose-binding Lectin Genotype Influences Frequency and Duration of Infectious Complications in Children With Malignancy, Journal of Pediatric Hematology/Oncology, 2013, 35, 1, 69

    CrossRef

  9. 9
    R. A. Ammann, N. Bodmer, A. Simon, P. Agyeman, K. Leibundgut, L. J. Schlapbach, F. K. Niggli, Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia, Journal of the Pediatric Infectious Diseases Society, 2013, 2, 2, 155

    CrossRef

  10. 10
    Sabine Heitzeneder, Markus Seidel, Elisabeth Förster-Waldl, Andreas Heitger, Mannan-binding lectin deficiency — Good news, bad news, doesn't matter?, Clinical Immunology, 2012, 143, 1, 22

    CrossRef

  11. 11
    Esther M. te Poele, Mateusz Siedlinski, P. J. Anne de Pagter, Marc B. Bierings, Frank J. G. Scherpen, Tiny G. J. Meeuwsen-de Boer, Gerard H. Koppelman, Dirkje S. Postma, Willem A. Kamps, H. M. Boezen, Eveline S. J. M. de Bont, MBL2 and fever during neutropenia in children with acute lymphoblastic leukaemia, British Journal of Haematology, 2012, 157, 1
  12. 12
    Mona Ghazi, Mina Isadyar, Latif Gachkar, Shima Mahmoudi, Hossein Goudarzi, Gita Eslami, Babak Pourakbari, Fatemeh Fallah, Serum Levels of Mannose-Binding Lectin and the Risk of Infection in Pediatric Oncology Patients With Chemotherapy, Journal of Pediatric Hematology/Oncology, 2012, 34, 2, 128

    CrossRef

  13. 13
    Therese Risom Vestergaard, Anders Juul, Ulrik Lausten-Thomsen, Birgitte Lausen, Henrik Hjalgrim, Tine Kajsa Kvist, Elisabeth Wreford Andersen, Kjeld Schmiegelow, Duration of Adrenal Insufficiency During Treatment for Childhood Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, 2011, 33, 6, 442

    CrossRef

  14. 14
    F.N.J. Frakking, J. Israëls, L.C.M. Kremer, T.W. Kuijpers, H.N. Caron, M.D. van de Wetering, Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy, Pediatric Blood & Cancer, 2011, 57, 1
  15. You have free access to this content15
    F. N. J. Frakking, N. Brouwer, K. M. Dolman, J. B. M. van Woensel, H. N. Caron, T. W. Kuijpers, M. D. van de Wetering, Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients, Clinical & Experimental Immunology, 2011, 165, 1
  16. 16
    Christine Rungoe, Emma Louise Malchau, Line Nordahl Larsen, Henrik Schroeder, Infections during induction therapy for children with acute lymphoblastic leukemia. The role of sulfamethoxazole–trimethoprim (SMX–TMP) prophylaxis., Pediatric Blood & Cancer, 2010, 55, 2
  17. 17
    Ekaterini Kidas, Anja Möricke, Rita Beier, Karl Welte, Martin Schrappe, Martin Stanulla, Lorenz Grigull, Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study, International Journal of Hematology, 2009, 89, 5, 584

    CrossRef

  18. 18
    L. Charles Bailey, Anne F. Reilly, Susan R. Rheingold, Infections in Pediatric Patients With Hematologic Malignancies, Seminars in Hematology, 2009, 46, 3, 313

    CrossRef

  19. 19
    Samina Afzal, Marie-Chantal Ethier, L Lee Dupuis, Laureen Tang, Angela S. Punnett, Susan E. Richardson, Upton Allen, Oussama Abla, Lillian Sung, Risk Factors for Infection-Related Outcomes During Induction Therapy for Childhood Acute Lymphoblastic Leukemia, The Pediatric Infectious Disease Journal, 2009, 28, 12, 1064

    CrossRef

  20. 20
    Florine N.J. Frakking, Nannette Brouwer, Marianne D. van de Wetering, Ilona Kleine Budde, Paul F.W. Strengers, Alwin D. Huitema, Inga Laursen, Gunnar Houen, Huib N. Caron, Koert M. Dolman, Taco W. Kuijpers, Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia, European Journal of Cancer, 2009, 45, 4, 505

    CrossRef

  21. 21
    R. Huttunen, J. Aittoniemi, J. Laine, R. Vuento, J. Karjalainen, A. T. Rovio, C. Eklund, M. Hurme, H. Huhtala, J. Syrjänen, Gene–environment Interaction between MBL2 Genotype and Smoking, and the Risk of Gram-positive Bacteraemia, Scandinavian Journal of Immunology, 2008, 68, 4
  22. 22
    Christoph Härtel, Maresa Deuster, Thomas Lehrnbecher, Christian Schultz, Current approaches for risk stratification of infectious complications in pediatric oncology, Pediatric Blood & Cancer, 2007, 49, 6
  23. 23
    Vivek Subbiah, Stephen J. Chanock, Modifiers of risk for infectious complications of cancer therapy in children: The long road ahead, Pediatric Blood & Cancer, 2007, 49, 1
  24. 24
    L.J. Schlapbach, C. Aebi, M. Otth, A. Ridolfi Luethy, K. Leibundgut, A. Hirt, R.A. Ammann, Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients, Pediatric Blood & Cancer, 2007, 49, 1